Feedback / Questions
Cardamyst (etripamil) - Milestone
https://www.manilatimes.net/2025/06/16/tmt-newswire/globenewswire/milestone-pharmaceuticals-submits-response-to-the-fdas-crl-for-cardamyst-etripamil-nasal-spray-for-psvt-following-type-a-meeting/2134053
Jun 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next